Literature DB >> 31308478

AAVrh-10 transduces outer retinal cells in rodents and rabbits following intravitreal administration.

Yong Zeng1, Haohua Qian2, Zhijian Wu2, Dario Marangoni1, Paul A Sieving1,2, Ronald A Bush3.   

Abstract

Recombinant adeno-associated virus (rAAV) has been widely used for gene delivery in animal models and successfully applied in clinical trials for treating inherited retinal disease. Although subretinal delivery of AAVs can effectively transduce photoreceptors and/or retinal pigmental epithelium (RPE), cells most affected by inherited retinal diseases, the procedure is invasive and complicated, and only delivers the gene to a limited retinal area. AAVs can also be delivered intravitreally to the retina, a much less invasive nonsurgical procedure. However, intravitreal administration of non-modified AAV serotypes tends to transduce only ganglion cells and inner nuclear layer cells. To date, most non-modified AAV serotypes that have been identified are incapable of efficiently transducing photoreceptors and/or RPE when delivered intravitreally. In this study, we investigate the retinal tropism of AAVrh10 vector administered by intravitreal injection to mouse, rat, and rabbit eyes. Our results demonstrate that AAVrh10 is capable of transducing not only inner retinal cells, but also outer retinal cells in all three species, though the transduction efficiency in rabbit was low. In addition, AAVrh10 preferentially transduced outer retinal cells in mouse models of retinal disease. Therefore, AAVrh10 vector could be a useful candidate to intravitreally deliver genes to photoreceptor and RPE cells.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31308478     DOI: 10.1038/s41434-019-0094-3

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  3 in total

1.  Gene therapy restores vision in a canine model of childhood blindness.

Authors:  G M Acland; G D Aguirre; J Ray; Q Zhang; T S Aleman; A V Cideciyan; S E Pearce-Kelling; V Anand; Y Zeng; A M Maguire; S G Jacobson; W W Hauswirth; J Bennett
Journal:  Nat Genet       Date:  2001-05       Impact factor: 38.330

2.  DNA-damaging agents greatly increase the transduction of nondividing cells by adeno-associated virus vectors.

Authors:  I E Alexander; D W Russell; A D Miller
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

3.  Gene expression changes within Müller glial cells in retinitis pigmentosa.

Authors:  Karin Roesch; Michael B Stadler; Constance L Cepko
Journal:  Mol Vis       Date:  2012-05-09       Impact factor: 2.367

  3 in total
  5 in total

1.  A 2020 vision of ocular gene therapy.

Authors:  Robert E MacLaren
Journal:  Gene Ther       Date:  2020-06-29       Impact factor: 5.250

2.  Retinal gene therapy: an eye-opener of the 21st century.

Authors:  Anne Louise Askou; Thomas Stax Jakobsen; Thomas J Corydon
Journal:  Gene Ther       Date:  2020-06-19       Impact factor: 5.250

3.  Rs1h-/y exon 3-del rat model of X-linked retinoschisis with early onset and rapid phenotype is rescued by RS1 supplementation.

Authors:  Yong Zeng; Haohua Qian; Maria Mercedes Campos; Yichao Li; Camasamudram Vijayasarathy; Paul A Sieving
Journal:  Gene Ther       Date:  2021-09-22       Impact factor: 4.184

4.  Novel AAV44.9-Based Vectors Display Exceptional Characteristics for Retinal Gene Therapy.

Authors:  Sanford L Boye; Shreyasi Choudhury; Sean Crosson; Giovanni Di Pasquale; Sandra Afione; Russell Mellen; Victoria Makal; Kaitlyn R Calabro; Diego Fajardo; James Peterson; Hangning Zhang; Matthew T Leahy; Colin K Jennings; John A Chiorini; Ryan F Boyd; Shannon E Boye
Journal:  Mol Ther       Date:  2020-04-11       Impact factor: 12.910

Review 5.  Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays.

Authors:  Thilo M Buck; Jan Wijnholds
Journal:  Int J Mol Sci       Date:  2020-06-12       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.